TP53 and hepatocellular carcinoma: These findings suggest that KIF20A may promote HCC progression by disrupting the p53-p21 or p53-E2F-G2M induced cell cycle arrest and suppressing apoptosis via blocking the p53-bax-bcl2-caspase3 pathways (Figure 4E), but further validation is required.